EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Classical and New Clinical Criteria for Diagnosing Familial Hypercholesterolemia in Childhood

Raffaele Buganza, Giulia Massini, Cecilia Nobili, Martina Ferrandino, Maria Donata Di Taranto, Luisa de Sanctis, Ornella Guardamagna

Cardiogenetics · 03.06.2026 · 16 (2) · 12

DOI: 10.3390/cardiogenetics16020012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiogenetics, online erschienen am 03.06.2026. Verfasst von Raffaele Buganza und 6 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heterozygous familial hypercholesterolemia (HeFH) is characterized by elevated low-density lipoprotein cholesterol (LDL-C) and increased cardiovascular risk, making early diagnosis essential; however, the diagnostic performance of pediatric criteria is heterogeneous. This study evaluated the effectiveness of different diagnostic criteria and scoring systems to select children for genetic testing. Materials and methods: A total of 214 pediatric subjects with suspected HeFH were included, recruited from patients followed at a tertiary care center, based on LDL-C levels ≥ 95th age- and sex-specific percentile in both the proband and one biological parent. All subjects underwent genetic analysis of the main FH-associated genes (LDLR, APOB, PCSK9). The following diagnostic criteria and scoring systems were retrospectively evaluated and compared with genetic findings: Simon Broome Register (SBR), Dutch Lipid Clinic Network (DLCN), European Atherosclerosis Society (EAS), American Heart Association (AHA), Familial Hypercholesterolemia Canada Network (FH-CAN), Japanese Atherosclerosis Society (JAS), Lipid TransPort Disorders Italian Genetic Network for Italian pediatric patients (LIPIGEN-FH-PED), and the Familial Hypercholesterolemia Pediatric Diagnostic Score (FH-PeDS).

Results

Pathogenic variants were identified in 91.8% of subjects. Approaches using lower LDL-C thresholds minimized the loss of variant-positive individuals (particularly JAS and FH-PeDS, with a missed diagnoses rate of 1.6%), whereas more restrictive definitions excluded a substantial proportion of affected patients (10.5% SBR, 56.3% DLCN, 6.3% EAS, 6.3% AHA, 7.4% FH-CAN, and 6.3% LIPIGEN-FH-PED). The mutation detection rate (MDR) was >91% for all examined criteria.

Conclusions

Several current diagnostic criteria may underestimate the true number of children carrying FH-associated variants. Less selective criteria enable the identification of a greater number of FH-positive individuals while maintaining a high MDR, thus supporting the prioritization of identifying as many affected children as possible in the pediatric setting. This cohort reflects a tertiary referral population rather than the general population; therefore, further studies are needed to evaluate the applicability of our findings to broader public health contexts and screening settings.

Zitieren

APA

Buganza, R., Massini, G., Nobili, C., Ferrandino, M., Taranto, M. D. D., Sanctis, L. D., & Guardamagna, O. (2026). Evaluation of Classical and New Clinical Criteria for Diagnosing Familial Hypercholesterolemia in Childhood. Cardiogenetics, 16(2), 12. https://doi.org/10.3390/cardiogenetics16020012

Vancouver

Buganza R, Massini G, Nobili C, Ferrandino M, Taranto MDD, Sanctis LD, et al. Evaluation of Classical and New Clinical Criteria for Diagnosing Familial Hypercholesterolemia in Childhood. Cardiogenetics. 2026;16(2):12. doi:10.3390/cardiogenetics16020012

BibTeX
@article{Buganza2026,
  author = {Buganza, Raffaele and Massini, Giulia and Nobili, Cecilia and Ferrandino, Martina and Taranto, Maria Donata Di and Sanctis, Luisa de and Guardamagna, Ornella},
  title = {Evaluation of Classical and New Clinical Criteria for Diagnosing Familial Hypercholesterolemia in Childhood},
  journal = {Cardiogenetics},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {12},
  doi = {10.3390/cardiogenetics16020012}
}
Kostenlos starten →